Klinikum Leverkusen

Industry / private company


Location: Leverkusen, Germany (DE) DE

ISNI: 0000000405595293

ROR: https://ror.org/05mt2wq31

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article Subtype specific expression of radioligand targets in the prospective Real World clinico-pathological register trial BRIDGister (2022) Wirtz R, Friedersdorff F, Barski D, Otto T, Bug R, Veltrup E, Kilic E, et al. Conference contribution CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome (2022) Taube F, Georgi JA, Kramer M, Stasik S, Middeke JM, Röllig C, Krug U, et al. Journal article Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment (2022) Harke NN, Wagner C, Hermann RM, Hadaschik BA, Radtke JP, Altay-Langguth A, Aufderklamm S, et al. Journal article Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease (2021) Pilgram L, Eberwein L, Wille K, Koehler FC, Stecher M, Rieg S, Kielstein JT, et al. Journal article Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics (2021) Tscharntke L, Jung N, Rieg S, Spinner C, Hanses F, Borgmann S, Wille K, et al. Conference contribution Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial (2021) Röllig C, Serve H, Noppeney R, Hanoun M, Krug U, Baldus CD, Brandts CH, et al. Journal article First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” (2020) Jakob CE, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, Friedrichs A, et al. Journal article Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis (2019) Boch T, Spiess B, Heinz W, Cornely OA, Schwerdtfeger R, Hahn J, Krause S, et al. Journal article Urology vision 2025 Urologie Vision 2025 (2019) Klotz T, Zumbe J, Wullich B Journal article, Editorial
1 2 3